Jan van de Winkel to deliver the Utrecht Science Lecture during the opening of Utrecht Science Week 2025
We are thrilled to announce that Prof. Dr. Jan van de Winkel, President & CEO of Genmab, will present the keynote opening Utrecht Science Lecture during the 2025 Utrecht Science Week on September 26. As a pioneering scientist and industry leader in antibody-based therapies, Jan van de Winkel has been at the forefront of groundbreaking advancements in immunotherapy, shaping the future of cancer treatment and beyond.
With more than 30 years of experience in therapeutic antibodies, Jan van de Winkel has played a pivotal role in translating cutting-edge science into life-changing medicines. As a co-founder of Genmab, he has led the company’s journey from an ambitious startup to a global end-to-end biotech powerhouse. In addition to his executive role, he holds a professorship in immunotherapy at Utrecht University, contributing to academic research and fostering the next generation of scientific leaders.
In his lecture, titled “Cracking the Code on Cancer and Other Serious Diseases: The Past, Present, and Future of Immunotherapy”, he will explore how immunotherapy is revolutionizing medicine. From early discoveries to today’s breakthroughs in cancer care, he will offer insights into the evolving role of antibody therapies, the next frontiers in biotechnology, and the power of collaboration and AI in driving innovation.
As Utrecht Science Week celebrates its fifth edition, this keynote lecture will highlight Utrecht’s ambition as the “Heart of Health” and the Utrecht Science Park as a unique life sciences ecosystem for cutting-edge research and medical innovation. Join us to gain a front-row perspective on the future of immunotherapy and how partnerships between academia, industry, and healthcare can accelerate progress for patients worldwide.
You can register here.
Princess Máxima Center and International Atomic Energy Agency join forces to improve radiotherapy treatments for children
In the presence of Her Majesty Queen Máxima, representatives of the Princess Máxima Center and the International Atomic Energy Agency (IAEA) today signed a four-year partnership aimed at improving practical knowledge on the use of radiotherapy for children with cancer.
MedTech sector launches national growth plan: technology must support Dutch healthcare and structurally strengthen economic growth
The Dutch MedTech sector is presenting an ambitious growth plan today that aims to elevate the Netherlands to the European top by 2035. UMC Utrecht contributed to this plan, and it was co-presented by Carina Hilders (Chair of the UMC Utrecht Executive Board).
Parking rates at Utrecht Science Park to change from 1 January 2026
From 1 January 2026, parking rates at Utrecht Science Park will be adjusted. The Municipality of Utrecht and the owners of the publicly accessible parking facilities at Utrecht Science Park have reached a joint agreement on this.
Wennink plan: Life Sciences and biotechnology are important growth drivers for the earning capacity of the Netherlands
The Dutch Life Sciences and biotechnology sector can make a much larger contribution to the Netherlands’ economic strength. This is shown in a new growth strategy presented today as part of Peter Wennink’s advisory report. The report also highlights Utrecht Science Park as one of the key innovation locations and sources of progress and growth.